Basic Information

Gene symbol CCNG1 Synonyms CCNG Type of gene protein-coding
Description cyclin G1

GTO ID GTC2351
Trial ID NCT04378244
Disease COVID-19
Altered gene CCNG1
Therapeutic/Target gene Therapeutic gene
TherapyGene transfer
Treatment DeltaRex-G
PhasePhase1|Phase2
Recruitment statusWithdrawn
TitleCORONA: A Phase 1/2 Study Using DeltaRex-G Gene Therapy for Symptomatic COVID-19
Year2020
CountryUnited States
Company sponsorAveni Foundation
Other ID(s)AF20-203
Vector information
Vectorretrovirus
Transgene/Inserted genecytocidal dominant negative human cyclin G1

Clinical Result

Cohort1: dose level 1
Administration route intravenous infusion
Dosage 1E11 cfu/dose
Age Adult, Older_Adult
Cohort2: dose level 2
Administration route intravenous infusion
Dosage 2E11 cfu/dose
Age Adult, Older_Adult
Cohort3: dose level 3
Administration route intravenous infusion
Dosage 3E11 cfu/dose
Age Adult, Older_Adult

Relationship Graph

Overview of Knowledge Graph